These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

398 related items for PubMed ID: 12436220

  • 1. Age and treatment of non-small-cell lung cancer: a database analysis in elderly patients.
    Berghmans T, Tragas G, Sculier JP.
    Support Care Cancer; 2002 Nov; 10(8):619-23. PubMed ID: 12436220
    [Abstract] [Full Text] [Related]

  • 2. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K, Podhipak A, Narksawat K, Supaattagorn P, Tipayamongkholgul M.
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [Abstract] [Full Text] [Related]

  • 3. Gender differences in non-small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002.
    Visbal AL, Williams BA, Nichols FC, Marks RS, Jett JR, Aubry MC, Edell ES, Wampfler JA, Molina JR, Yang P.
    Ann Thorac Surg; 2004 Jul; 78(1):209-15; discussion 215. PubMed ID: 15223430
    [Abstract] [Full Text] [Related]

  • 4. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 5. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD, Paulus R, Graham MV, Ettinger DS, Johnstone DW, Pilepich MV, Machtay M, Komaki R, Atkins J, Curran WJ, Radiation Therapy Oncology Group.
    J Clin Oncol; 2005 May 20; 23(15):3480-7. PubMed ID: 15908657
    [Abstract] [Full Text] [Related]

  • 6. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA, Bernardo P, Johnson DH, Schiller JH.
    Cancer; 2006 May 15; 106(10):2208-17. PubMed ID: 16604529
    [Abstract] [Full Text] [Related]

  • 7. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
    Yovino S, Kwok Y, Krasna M, Bangalore M, Suntharalingam M.
    Int J Radiat Oncol Biol Phys; 2005 Aug 01; 62(5):1438-43. PubMed ID: 16029805
    [Abstract] [Full Text] [Related]

  • 8. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S, Bremnes R, Aasebø U, Aamdal S, Hatlevoll R, Brunsvig P, Johannessen DC, Klepp O, Fayers PM, Kaasa S.
    J Clin Oncol; 2004 Mar 01; 22(5):801-10. PubMed ID: 14990635
    [Abstract] [Full Text] [Related]

  • 9. Complications and outcomes after pulmonary resection for cancer in patients 80 to 89 years of age.
    Matsuoka H, Okada M, Sakamoto T, Tsubota N.
    Eur J Cardiothorac Surg; 2005 Sep 01; 28(3):380-3. PubMed ID: 16054820
    [Abstract] [Full Text] [Related]

  • 10. Comparison of curative and palliative radiotherapy efficacy in unresectable advanced non-small cell lung cancer patients with or without metastasis.
    Unlu I, Diniz G, Komurcuoglu B, Gayaf M, Gokce T, Karadogan I, Akcay C.
    Saudi Med J; 2006 Jun 01; 27(6):849-53. PubMed ID: 16758049
    [Abstract] [Full Text] [Related]

  • 11. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
    Costa GJ, Fernandes AL, Pereira JR, Curtis JR, Santoro IL.
    Lung Cancer; 2006 Aug 01; 53(2):171-6. PubMed ID: 16757059
    [Abstract] [Full Text] [Related]

  • 12. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
    Birim O, Kappetein AP, Goorden T, van Klaveren RJ, Bogers AJ.
    Ann Thorac Surg; 2005 Sep 01; 80(3):1021-6. PubMed ID: 16122477
    [Abstract] [Full Text] [Related]

  • 13. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification].
    Pfannschmidt J, Muley T, Hoffmann H, Bülzebruck H, Dienemann H.
    Dtsch Med Wochenschr; 2006 Nov 24; 131(47):2643-8. PubMed ID: 17109272
    [Abstract] [Full Text] [Related]

  • 14. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M, Lee JH, Stevenson JP, Shrager JB, Algazy KM, Treat J, Kaiser LR.
    J Thorac Cardiovasc Surg; 2004 Jan 24; 127(1):108-13. PubMed ID: 14752420
    [Abstract] [Full Text] [Related]

  • 15. Favorable surgical results for patients with nonsmall cell lung cancer over 80 years old: a multicenter survey.
    Suemitsu R, Yamaguchi M, Takeo S, Ondo K, Ueda H, Yoshino I, Maehara Y.
    Ann Thorac Cardiovasc Surg; 2008 Jun 24; 14(3):154-60. PubMed ID: 18577893
    [Abstract] [Full Text] [Related]

  • 16. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C, Chang EL, Hassenbusch SJ, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z.
    Cancer; 2006 May 01; 106(9):1998-2004. PubMed ID: 16572401
    [Abstract] [Full Text] [Related]

  • 17. Survival in untreated early stage non-small cell lung cancer.
    Chadha AS, Ganti AK, Sohi JS, Sahmoun AE, Mehdi SA.
    Anticancer Res; 2005 May 01; 25(5):3517-20. PubMed ID: 16101172
    [Abstract] [Full Text] [Related]

  • 18. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study.
    Hata M, Tokuuye K, Kagei K, Sugahara S, Nakayama H, Fukumitsu N, Hashimoto T, Mizumoto M, Ohara K, Akine Y.
    Int J Radiat Oncol Biol Phys; 2007 Jul 01; 68(3):786-93. PubMed ID: 17379439
    [Abstract] [Full Text] [Related]

  • 19. Age and comorbidity as independent prognostic factors in the treatment of non small-cell lung cancer: a review of National Cancer Institute of Canada Clinical Trials Group trials.
    Asmis TR, Ding K, Seymour L, Shepherd FA, Leighl NB, Winton TL, Whitehead M, Spaans JN, Graham BC, Goss GD, National Cancer Institute of Canada Clinical Trials Group.
    J Clin Oncol; 2008 Jan 01; 26(1):54-9. PubMed ID: 18165640
    [Abstract] [Full Text] [Related]

  • 20. Non-small cell lung cancer in the young: a retrospective analysis of diagnosis, management and outcome data.
    Mauri D, Pentheroudakis G, Bafaloukos D, Pectasides D, Samantas E, Efstathiou E, Kalofonos HP, Syrigos K, Klouvas G, Papakostas P, Kosmidis P, Fountzilas G, Pavlidis N, Hellenic Coopeprative Oncologic Group (HeCOG).
    Anticancer Res; 2006 Jan 01; 26(4B):3175-81. PubMed ID: 16886653
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.